131 related articles for article (PubMed ID: 27457778)
1. Hepatoblastoma in Explanted Livers of Patients With Biliary Atresia.
Amir AZ; Sharma A; Cutz E; Avitzur Y; Shaikh F; Kamath BM; Ling SC; Ghanekar A; Ng VL
J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):188-94. PubMed ID: 27457778
[TBL] [Abstract][Full Text] [Related]
2. Serum α-fetoprotein concentration in extremely low-birthweight infants.
Maruyama K
Pediatr Int; 2017 Feb; 59(2):159-162. PubMed ID: 27400853
[TBL] [Abstract][Full Text] [Related]
3. Pretransplant trends in α-fetoprotein levels as a predictor of recurrence after living donor liver transplantation for unresectable hepatoblastoma: A single-institution experience.
Isono K; Ohya Y; Lee KJ; Hashimoto S; Kadohisa M; Sakisaka M; Uto K; Hayashida S; Yamamoto H; Yamamoto H; Sugawara Y; Inomata Y
Pediatr Transplant; 2018 Aug; 22(5):e13221. PubMed ID: 29761829
[TBL] [Abstract][Full Text] [Related]
4. Hepatoblastoma in a girl with biliary atresia: coincidence or co-incidence.
Taat F; Bosman DK; Aronson DC
Pediatr Blood Cancer; 2004 Oct; 43(5):603-5. PubMed ID: 15382280
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma in biliary atresia: King's College Hospital experience.
Hadžić N; Quaglia A; Portmann B; Paramalingam S; Heaton ND; Rela M; Mieli-Vergani G; Davenport M
J Pediatr; 2011 Oct; 159(4):617-22.e1. PubMed ID: 21489554
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for biliary atresia associated with malignant hepatic tumors.
Tatekawa Y; Asonuma K; Uemoto S; Inomata Y; Tanaka K
J Pediatr Surg; 2001 Mar; 36(3):436-9. PubMed ID: 11226990
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study.
Kinoshita Y; Tajiri T; Souzaki R; Tatsuta K; Higashi M; Izaki T; Takahashi Y; Taguchi T
J Pediatr Hematol Oncol; 2008 Jun; 30(6):447-50. PubMed ID: 18525461
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.
Koh KN; Park M; Kim BE; Bae KW; Kim KM; Im HJ; Seo JJ
Pediatr Blood Cancer; 2011 Oct; 57(4):554-60. PubMed ID: 21370433
[TBL] [Abstract][Full Text] [Related]
9. Early occurrence of hepatocellular carcinoma in biliary atresia treated by liver transplantation.
Brunati A; Feruzi Z; Sokal E; Smets F; Fervaille C; Gosseye S; Clapuyt P; de Ville de Goyet J; Reding R
Pediatr Transplant; 2007 Feb; 11(1):117-9. PubMed ID: 17239135
[TBL] [Abstract][Full Text] [Related]
10. Glypican 3 as a Serum Marker for Hepatoblastoma.
Zhou S; O'Gorman MR; Yang F; Andresen K; Wang L
Sci Rep; 2017 Apr; 7():45932. PubMed ID: 28378832
[TBL] [Abstract][Full Text] [Related]
11. Hepatic tumours in children with biliary atresia: single-centre experience in 13 cases and review of the literature.
Yoon HJ; Jeon TY; Yoo SY; Kim JH; Eo H; Lee SK; Kim JS
Clin Radiol; 2014 Mar; 69(3):e113-9. PubMed ID: 24332171
[TBL] [Abstract][Full Text] [Related]
12. Timing of liver transplantation in biliary atresia-results in 71 children managed by a multidisciplinary team.
Cowles RA; Lobritto SJ; Ventura KA; Harren PA; Gelbard R; Emond JC; Altman RP; Jan DM
J Pediatr Surg; 2008 Sep; 43(9):1605-9. PubMed ID: 18778993
[TBL] [Abstract][Full Text] [Related]
13. High survival rates after liver transplantation for hepatoblastoma and hepatocellular carcinoma.
Kosola S; Lauronen J; Sairanen H; Heikinheimo M; Jalanko H; Pakarinen M
Pediatr Transplant; 2010 Aug; 14(5):646-50. PubMed ID: 20345611
[TBL] [Abstract][Full Text] [Related]
14. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.
Van Tornout JM; Buckley JD; Quinn JJ; Feusner JH; Krailo MD; King DR; Hammond GD; Ortega JA
J Clin Oncol; 1997 Mar; 15(3):1190-7. PubMed ID: 9060563
[TBL] [Abstract][Full Text] [Related]
15. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
[TBL] [Abstract][Full Text] [Related]
16. Relapse surveillance in AFP-positive hepatoblastoma: re-evaluating the role of imaging.
Rojas Y; Guillerman RP; Zhang W; Vasudevan SA; Nuchtern JG; Thompson PA
Pediatr Radiol; 2014 Oct; 44(10):1275-80. PubMed ID: 24839140
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing jaundice-free survival with the native liver in post-portoenterostomy biliary atresia patients: results from a single institution.
Koga H; Wada M; Nakamura H; Miyano G; Okawada M; Lane GJ; Okazaki T; Yamataka A
J Pediatr Surg; 2013 Dec; 48(12):2368-72. PubMed ID: 24314172
[TBL] [Abstract][Full Text] [Related]
18. The Utility of Serum Alpha-fetoprotein for Monitoring for Relapse of Alpha-fetoprotein-Positive Hepatoblastoma.
Davini M; Hastings C; Feusner J
J Pediatr Hematol Oncol; 2024 May; 46(4):206-210. PubMed ID: 38551915
[TBL] [Abstract][Full Text] [Related]
19. Circulating D-dimer level correlates with disease characteristics in hepatoblastoma patients.
Zhang B; Liu G; Liu X; Zheng S; Dong K; Dong R
Medicine (Baltimore); 2017 Nov; 96(47):e8798. PubMed ID: 29381980
[TBL] [Abstract][Full Text] [Related]
20. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience.
De Ioris M; Brugieres L; Zimmermann A; Keeling J; Brock P; Maibach R; Pritchard J; Shafford L; Zsiros J; Czaudzerna P; Perilongo G
Eur J Cancer; 2008 Mar; 44(4):545-50. PubMed ID: 18166449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
